Association Between Toxic Effects and Survival in Patients With Cancer and Autoimmune Disease Treated With Checkpoint Inhibitor Immunotherapy
Catherine Y. Han, Conall Fitzgerald, Mark Lee, Cristina Valero, Mithat Gönen, Alexander N. Shoushtari, Luc G.T. Morris
Abstract
This cohort study analyzed the safety and efficacy of immune checkpoint inhibitors in patients with cancer and autoimmune disease, and examined whether immune-related toxic effects were associated with outcomes.
Topics & Concepts
MedicineImmunotherapyCancerDiseaseAutoimmune diseaseOncologyImmunologyInternal medicineCTLA-4Immune systemT cellCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesChronic Lymphocytic Leukemia Research